Making the Most of Complexity to Create Opportunities: Comprehensive Genomic Profiling and Molecular Tumor Board for Patients with Non-Small Cell Lung Cancer (NSCLC)
Personalized cancer therapy matches the plan of treatment with specific molecular alterations [...]
Main Authors: | Caterina Fumagalli, Elena Guerini-Rocco, Massimo Barberis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/4/609 |
Similar Items
-
Genomic Characterization of Concurrent Alterations in Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Mutations
by: Antonio Passaro, et al.
Published: (2021-04-01) -
Diagnostic and Predictive Biomarkers in Lung Cancer
by: Caterina Fumagalli, et al.
Published: (2021-05-01) -
Hollywood’s most reliable audience. Il pubblico adolescente tra consumo, narrazioni e partecipazione
by: Stefano Guerini Rocco
Published: (2020-01-01) -
Breast Cancer Heterogeneity
by: Caterina Fumagalli, et al.
Published: (2021-08-01) -
Diagnostic bronchoscopy: a window of opportunity for timely biomarker driven therapy in non-small cell lung cancer (NSCLC)
by: Medley, L, et al.
Published: (2009)